Archived: ACT-Accelerator funding tracker

Archived: ACT-Accelerator funding tracker

WHO/G. Soupe
Testing for COVID-19 at the Jawaharlal Nehru Hospital. Samples are sent to the Candos Virology Lab in Quatre Bornes and results are received in around 2 days.
© Credits

Archived: The ACT Accelerator funding tracker

Please note that the content on this page is no longer current, as updates ended in October 2021, due to the conclusion of the collaboration with the Economist Intelligence Unit. However, the data used in this visualization continues to be updated every 2 weeks and can be found on this tracker page. 

The ACT Accelerator Commitment Tracker provides transparent reporting on funding commitments made against ACT Accelerator Pillar budgets. The ACT-Accelerator Prioritized Strategy and Budget for 2021 provides further detail.

 

The ACT Accelerator has partnered with the Wellcome Trust and the Economist Intelligence Unit to present an interactive visualization of commitments made to ACT Accelerator.

Contributions from the Diagnostics Consortium for COVID-19 reflect the value of tests procured by Consortium members for LMICs.  These contributions reduce the Diagnostics Pillar funding gap. Consortium contributions are made directly to countries, not via an ACT-A agency.

The interactive ACT Accelerator's Funding Commitment Tracker visualizes funding commitments made against the pillars: vaccines, therapeutics, diagnostics and health systems, showing both the source and recipient organization for each funding item. Historical funding trends can also be viewed, dating back to March 2020. 

Quick and substantial action to fulfill these financing requirements will maximize the impact of the ACT Accelerator, through aiding in the faster development and deployment of additional game-changing tools and mitigating the risk of a widening gap in access to COVID-19 tools between low- and high-income countries.

ACT-Accelerator Pillar co-conveners contribute the source data and all amounts are in USD and subject to ForEx variations.

For additional information please contact ACTaccelerator@who.int

 

News